A detailed history of Us Bancorp \De\ transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 3,719 shares of MRVI stock, worth $19,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,719
Previous 3,455 7.64%
Holding current value
$19,413
Previous $24,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$6.84 - $9.73 $1,805 - $2,568
264 Added 7.64%
3,719 $30,000
Q2 2024

Aug 06, 2024

SELL
$6.87 - $11.34 $604 - $997
-88 Reduced 2.48%
3,455 $24,000
Q1 2024

May 07, 2024

SELL
$5.11 - $8.76 $2,095 - $3,591
-410 Reduced 10.37%
3,543 $30,000
Q4 2023

Feb 09, 2024

BUY
$4.7 - $9.87 $3,200 - $6,721
681 Added 20.81%
3,953 $25,000
Q3 2023

Nov 03, 2023

BUY
$9.14 - $12.85 $21,570 - $30,326
2,360 Added 258.77%
3,272 $32,000
Q2 2023

Aug 09, 2023

SELL
$12.09 - $15.0 $61,622 - $76,455
-5,097 Reduced 84.82%
912 $11,000
Q1 2023

May 09, 2023

BUY
$12.99 - $16.48 $32,111 - $40,738
2,472 Added 69.89%
6,009 $84,000
Q4 2022

Feb 13, 2023

SELL
$12.5 - $24.78 $223,312 - $442,694
-17,865 Reduced 83.47%
3,537 $50,000
Q3 2022

Oct 27, 2022

SELL
$20.6 - $30.37 $643,832 - $949,183
-31,254 Reduced 59.36%
21,402 $547,000
Q2 2022

Aug 01, 2022

BUY
$26.05 - $37.48 $1.37 Million - $1.97 Million
52,555 Added 52034.65%
52,656 $1.5 Million
Q1 2022

May 11, 2022

SELL
$24.46 - $40.92 $1,369 - $2,291
-56 Reduced 35.67%
101 $4,000
Q4 2021

Feb 11, 2022

SELL
$35.0 - $45.94 $14,595 - $19,156
-417 Reduced 72.65%
157 $6,000
Q3 2021

Nov 10, 2021

SELL
$36.8 - $60.62 $147 - $242
-4 Reduced 0.69%
574 $28,000
Q2 2021

Aug 05, 2021

BUY
$32.46 - $45.0 $17,333 - $24,030
534 Added 1213.64%
578 $24,000
Q4 2020

Feb 04, 2021

BUY
$24.5 - $30.86 $1,078 - $1,357
44 New
44 $1,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.